The effect of Montelukast in the treatment of cystitis

Evalution the effect of Montelukast in the treatment of Children with cystitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220203053919N1

Enrollment

Registered

2022-02-12

Start date

2022-03-11

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystitis. Cystitis

Interventions

Intervention 1: Control group: In the control group of 28 patients, only standard treatment of cystitis is prescribed orally with cefixime (Sobhan Daroo-Iran) at a dose of 8 mg / kg daily for 10 days.

Eligibility

Sex/Gender

All

Age

5 Years to 15 Years

Inclusion criteria

Inclusion criteria: age 5 to 15 years clinical diagnosis of cystitis History of allergy

Exclusion criteria

Exclusion criteria: Fever Any complications associated with the disease

Design outcomes

Primary

Measure	Time frame
Clinical symptoms of cystitis. Timepoint: From the beginning of the intervention on a daily basis for 10 days. Method of measurement: Biography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamadreza Mokhtari

Arak University of Medical Sciences

infa@arakmu.ac.ir+98 86 3313 6055

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026